Scott Rocklage Continues to Expand Reserach for DM1 Disorders

Recently Expansion Therapeutics raised over $55.3 million for research for the development of drugs that target genetic diseases that cause adult muscular dystrophy. The financing was lead by several companies including 5AM Ventures.

DM1 a substance that causes these genetic repeat disorders is caused by production of toxic molecules that turn into proteins inside the cells. This leads to problems with the heart, nervous system, respiratory system, muscles, stomach, and hormones. This can affect entire families and to date there is no known treatment for the disease. Read more: Scott Rocklage | Ideamesch and Scott Rocklage | Angel

Expansion Therapeutics specializes in developing drugs that target diseases caused by RNA. It focuses on disease that have no treatment or cure. Scott M. Rocklage managing partner of 5M Ventures and chairman of the board of directors of Expansion Therapeutics says the drugs they develop are based on research performed by Matthew D. Disney Ph.D of Scripps Research Institute.

Rocklage said that Disney was the key scientific founder of the team The company has put together a research team and a plan to advance the field of RNA medicine. They want to develop new medicines for patients that have few treatment options available.

Scott Rocklage went to the University of California Berkley. He received a B.A. in Chemistry. Later he went on to receive a Ph.D in Chemistry from the Massachusetts Institute of Technology. While at MIT he conducted research and worked in the lab.

In 2005, he received the Nobel Peace Prize in Chemistry. He joined 5AM Ventures in 2003 as a venture partner and later became a managing partner. Dr. Rocklage was responsible for FDA approval of three drugs. He has submitted numerous drugs for clinical trail studies.

Scott Rocklage owns over 30 US patents and many of his articles published have been peer reviewed. At one time he was chairman and CEO of Cubist Pharmaceuticals and held many R & D positions at different companies.

Ted Bauman Helps Clients Realize Investing Potential

In his position as an investment advisor, Ted Bauman has tried to always give people the chances they need for investment. In fact, he has always wanted to make sure he can give back to the clients he works with. If he can give them positive investment advice, he knows it will give him the chances he needs to continue being successful at both Banyan Hill Publishing and the Bauman Letter. Ted Bauman likes to show his customers they can try different things and they can do more with the industry standards he has put into place.

In addition, Ted Bauman has always wanted to let his customers know there will be a positive part that comes from the industry. He has shown them the right way to help themselves and the right investments they need, now he hopes they will be able to use the strategies on their own. Instead of just taking the money from them and investing it at will, Ted Bauman shows them how they can use their own money and invest it by themselves. As an advisor, he wants to teach people what they can do to make money instead of what they will need to do to try to work with him only. Read more about Ted Bauman at Ezine Articles

One thing Ted Bauman has vehemently insisted on is that Bitcoin is a poor investment choice. Not only is it hard to invest in something that doesn’t exist in real life, but it makes things worse for people who want to actually make money. They will not be able to use the cryptocurrency in the same way they would use other types of money. In fact, it would just not even be as fast as a credit card transaction if they wanted to be able to make a difference in the money they were using.

Cryptocurrency has no future as a currency. People who are trying to invest their money will soon realize the currency portion won’t work. It is hard for others to grasp because they know they can use it online, but it takes much longer to use it in a brick and mortar setting. It can take almost an hour to complete a transaction. In the busy world that is all around people, it would not make sense to have to wait an hour to get the currency they need or to pay for the things they can use.

Check this link:http://www.talkmarkets.com/contributor/Ted-Bauman

 

Can the Fear-mongering Commodity Uranium Make a Price Comeback in 2018?

Is the fearsome and a potentially high damage causing commodity uranium about to see better times ahead after peaking at its lowest in October 2016? Quite possibly yes, as per Matt Badiali’s analysis for uranium in 2018.

The downfall of uranium began in 2011 after the frightening occurrence of the Fukushima disaster in Japan. It alerted everyone to its high potential of causing energy disasters in the aftermath of unpreventable failures such as earthquakes and tsunamis.

The uranium price, before its downtrend, was sold for $72.50 per pound in January 2011. It fell to a shocking low price of $18.75 per pound in 2016. The steady decline of uranium came as a shocking reality, considering the “green” status attributed to it. Even the belief (as held by many) that uranium reduces greenhouse emission, compared to its counterpart hydrocarbon, couldn’t aid its fall.

Apparently, the Fukushima natural disaster enabled many to realize the storage problems of uranium and it seems they plan to cling to this perception for now. But what exactly was so impactful in retaining this concern?

When the earthquake and tsunami struck the region of Fukushima Daiichi nuclear power plant in March 2011, the earth disaster damaged a reactor. This was followed by the tsunami that inundated the area, destroying the backup generators that were supposed to maintain the temperature in the absence of the main power source. Without any functioning power, the cooling water couldn’t reach the plant to prevent radiation meltdown. This paved way for the greatest nightmare of any nuclear power plant operator to come true.

A lack of foresight into possible mishaps contributed to this error largely. The Tokyo Electric Power Company that operated the nuclear plant was unprepared for this situation. The result created a rippling effect. Many countries became wary of nuclear power reactors, with Germany going so far as to shut down all its nuclear reactors. As a result, demand for uranium fell and so did its price.

In November 2017, the uranium production mine, Cameco Corp, cut production after continuing to witness the fall of uranium prices. The struggle to maintain profitability, led to the decision to suspend operations for ten months at its flagship McArthur River mine. Kazatomprom, Kazakhstan’s state-sponsored uranium miner, followed suit and cut down on uranium production by 20%.

Matt Badiali’s chart demonstrated that shares of Uranium Participation Corp. dropped in response to this development. Shares of other uranium companies plunged as well.

Analysts believe the price of uranium can gain $30 per pound from these cuts in the coming year. This possibility will be a windfall for uranium producers. Companies like Cameco will experience revenue and earnings spike up. This trend will be closely observed into 2018.

Energy expert Matt Badiali, has an in depth knowledge in mining, agricultural and fossil industries. He’s analyzed many CEO schemes and observed trends in the stock market. His foresight is based off his experience and knowledge regarding many different fields in which he has closely interacted with professionals and experts. He continues to enlighten us with his perceptible predictions regarding good and useful investments.

Follow:https://twitter.com/Matt_B_Guru

Legacy Building

Compensating employees with stocks is not always the best way to go, especially with so much regulator scrutiny placed on most all transactions of an appreciable size. Jeremy Goldstein, an attorney with his own firm who advises on all kinds of employee compensation packages, has an alternative to stock options for senior level executives. The solution he has is called a “knockout option.” There are a number of reasons why stock options are not good, including stock value drops, which serve to negate the selling option often times, and for employers, they represent an accounting challenge. The costs of managing these options are greater than the benefits of the programs at times.

 

Knockout options have most of the same features as stock options, including time limits and tenure-of-service clauses, but they differ in what happens if the stock value falls under a certain amount. Employees will lose knockout options if a preset value is breached. These types of options give employees the right to purchase stock at a particular price, and invariably a 50% drop from the knockout option price will mark the expiration value. This is not automatic, however, and most of the time these deals are structured so that the price has to remain below the expiration value for a period of time, perhaps a week.

 

Prior to starting his own firm specializing in helping companies manage employee compensation packages, Jeremy Goldstein worked on a number of large-scale acquisitions as a partner at a large New York law firm. During that time he worked on several M&A deals, including Goldman Sachs and Kinder Morgan, and the Verizon Wireless/Alltell deal. He also served on the American Bar Association’s Executive Compensation Committee.

 

A stalwart in his field, Mr. Goldstein was nominated top legal talent in executive compensation by the publication “Legal 500.” Having graduated from the University of Chicago, with honors, and going on to New York University School of Law, where he received his J.D., Jeffrey Goldstein is creating a legacy of great work in employee compensation plans that work for employees and employers alike. Learn more: https://profiles.superlawyers.com/new-york-metro/new-york/lawfirm/jeremy-l-goldstein-and-associates-llc/a958e5a0-ace7-44fa-8f53-da9d83c3b29b.html